菌体-抗生素结合物可用于针对性治疗感染
Yi Zhao1, Wenxin Chen1, Haixin Bi1
1School of Life and Health Sciences, HainanProvince Key Laboratory of One Health, Collaborative Innovation Center of OneHealth, Hainan University, Haikou 570228, China.
Colloids and surfaces. B, Biointerfaces
|June 20, 2025
概括
这项研究引入了一种新型的菌体-万科米辛结合物 (Van@vB_C4),用于治疗耐药细菌感染. 这种结合物增强了局部抗生素的输送,提高了对抗性细菌和生物膜的疗效.
科学领域:
- 微生物学 微生物学
- 细菌学 细菌学是一门学科.
- 治疗药物开发 治疗药物开发
背景情况:
- 菌体-抗生素联合治疗显示出对抗药性细菌感染的前景.
- 简单的组合往往在减少抗生素使用和预防耐药性的有效性有限.
- 需要有针对性的输送系统来提高组合疗法的有效性.
研究的目的:
- 开发和评估一种菌体-万科米辛结合物 (Van@vB_C4),用于增强万科米辛的输送.
- 评估Van@vB_C4对抗抗菌素耐药性Aeromonas veronii C4 (VR A. veronii C4) 的抗菌活性.
- 在小鼠模型中研究Van@vB_C4在对抗细菌生物膜和减少感染方面的有效性.
主要方法:
- 范素 (Van) 与细菌体vB_C4的结合,形成Van@vB_C4.
- 在体外评估对VR A. veronii C4及其生物膜的抗菌活性.
- 在VR A. veronii C4感染的小鼠模型中对Van@vB_C4的体内评估,包括器官殖民和炎症反应分析.
主要成果:
- Van@vB_C4成功地输送了万科米辛,在目标细菌附近实现了局部高度.
- 与简单的菌体和万科米的组合相比,联合体对VR A. veronii C4具有优越的抗菌活性.
- Van@vB_C4有效地根除了50%以上的成熟细菌生物膜,并显著减少了小鼠器官中的细菌殖民,同时也减轻了炎症.
结论:
- 菌体-抗生素结合剂提供了一种有针对性的方法来提高治疗疗效.
- Van@vB_C4为治疗抗万科胺素的细菌感染提供了有效的策略,包括生物膜.
- 这种方法为菌体-抗生素联合治疗在对抗多药耐药细菌方面开辟了新的途径.
相关概念视频
Lytic Cycle of Bacteriophages
72.3K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
72.3K
Lysogenic Cycle of Bacteriophages
63.4K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
63.4K
Antibiotic Selection
55.4K
Overview
55.4K
DNA Bacteriophages
168
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
168
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Antibody Actions
1.4K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.4K


